After Negative FDA Committee Vote, Jazz Has Few Notes To Play Beyond Fibromyalgia

Jazz's reformulation of sodium oxybate for fibromyalgia ran into advisory committee skepticism last week, but at least one analyst predicts FDA will override the 20-2 negative vote.